Now I have a thorough understanding of the paper and the calibration anchors. Let me synthesize the final review.

**Review of calibration anchors for scoring:**

- **cESVZ0SfjA (1.50, Reject)**: "Label Transfer Hypothesis" — claimed a theoretical framework with no theory, tiny experiments, no SOTA baselines. Our paper is substantially stronger on all dimensions.
- **K5tcKEQaUr (4.00, Accept Poster)**: "RetMAE" — frequency-balanced MAE for retinal images. Limited novelty, narrow experiments. Our paper has broader experiments and more architectural contribution, but RetMAE's core claims were validated. Comparable tier.
- **9gc58FeBba (5.00, Reject)**: "ProConMV" — multi-view DR with synthetic inputs, excessive complexity. Our paper is cleaner but shares the multi-view DR domain. Our paper has similar empirical breadth but cleaner methodology. Slightly better.
- **S5Io33pc78 (6.50, Accept Poster)**: "MAMMOTH" — MoE for MIL, extremely comprehensive across 8 methods × 19 tasks. Our paper's experiments are narrower and the lesion proposal claim is unvalidated, so we're clearly below this tier.

**Verdict**: The paper falls around **5.0**. It has real contributions (GALP+LGRF modules, strong results, good ablations) but the central "lesion proposal" claim lacks direct validation, which is a significant weakness that prevents it from reaching the 6+ tier.

---

## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy (DR) grading that generates lesion proposals on the fly via a Grade-Activated Lesion Proposal (GALP) module and fuses them across views through a Cross-View Lesion Expert-Guided Regional Fusion (LGRF) module. The key contribution is that the method self-generates informative cues without requiring costly external annotations (lesion masks, vessel maps, optic disc coordinates). On two multi-view DR benchmarks (MFIDDR 4-view and DRTiD 2-view), the method matches or surpasses several externally informed baselines while operating fully annotation-free, and achieves state-of-the-art results when external lesion annotations are optionally incorporated.

## Strengths

- **Strong empirical results without external annotations.** On MFIDDR (Table 1), the lesion-free variant reaches 83.9% accuracy, outperforming all end-to-end baselines and matching or exceeding several externally informed methods (e.g., LFMVDR at 82.2%, CVSA at 82.6%). On DRTiD (Table 3), the method achieves 76.0% accuracy — surpassing the previous best externally informed method CrossFiT (75.6%) — while requiring no OD/macula coordinates or other side information.

- **Well-structured ablation study isolates module contributions.** Table 4 shows that removing GALP drops accuracy by 1.2%, removing LGRF drops it by 1.6%, and removing the expert pool further degrades performance. These controlled comparisons on the same Swin-B backbone confirm that both the self-derived proposal mechanism and the cross-view fusion design contribute meaningfully beyond the backbone alone.

- **Generalizability demonstrated across two different multi-view datasets and protocols.** The method is evaluated on four-view (MFIDDR, 224×224) and two-view (DRTiD, 512×512) setups with different backbone initializations (ImageNet vs. EyePACS), showing consistent gains over both end-to-end and externally informed baselines in both settings.

- **The LGRF module introduces a genuinely novel MoE routing mechanism for cross-view fusion.** Using current-view tokens to gate expert activation on adjacent-view lesion proposals (Eqs. 9-10) and applying Top-K-weighted cross-view attention is a non-trivial design. The hyperparameter study (Fig. 3) shows that retaining 50% of tokens and activating 2 of 6 experts yields the best accuracy-efficiency trade-off, validating the design choices empirically.

- **The appendix comparison with single-view methods (Table 5) is compelling.** Multi-view Swin-B with GALP+LGRF achieves 83.9% vs. single-view Swin-B at 75.0%, confirming that the cross-view pipeline exploits complementary information far beyond what a stronger backbone alone provides.

## Weaknesses

### Fatal

None.

### Major

- **The claim that GALP produces "lesion proposals" is unvalidated.** The paper's title, abstract, and motivation center on generating *lesion* proposals that can replace clinician-provided lesion annotations. However, no evidence demonstrates that the selected Top-K CAM patches correspond to actual DR lesions (microaneurysms, hemorrhages, exudates, etc.). The paper states that the MFIDDR dataset includes lesion segmentation masks (Section 4.1), but no qualitative visualizations, quantitative overlap metrics (e.g., patch-wise precision/recall against lesion masks), or any other validation of the "lesion" label is provided. The GALP module selects high-activation regions from auxiliary classifiers; these could be grade-salient but non-lesion anatomy (e.g., optic disc, vessels, or background regions spuriously correlated with grade). The ablation showing GALP helps performance is indirect evidence that the module is useful, but it does not validate that the proposals are *lesions*. This weakens the paper's central narrative — the method is more accurately described as generating "grade-salient proposals" rather than "lesion proposals," which substantially reduces the force of the annotation-reduction story. The authors should either validate the lesion correspondence against the available masks or recalibrate their claims.

### Minor

- **Cross-view fusion is restricted to a single cyclic adjacent view.** In the four-view MFIDDR benchmark, each view fuses only with its immediate neighbor (i+1 mod N), ignoring two other views that likely contain complementary lesion evidence. No justification is provided for this design choice, and no ablation compares cyclic single-neighbor fusion against all-to-all or bidirectional fusion. This may artificially limit the benefits of multi-view integration. Given the strong results, this likely does not change the overall conclusions but is a missed opportunity for a stronger contribution.

- **Backbone differences between the proposed method and baseline approaches are not fully controlled.** The method uses Swin-B, while several baselines (e.g., MVCINN, ETMC, MVCNN variants) use older or lighter backbones. The paper does not re-run representative baselines with Swin-B. However, the internal ablation study (Table 4) uses the same backbone throughout and still shows clear gains from GALP and LGRF. Additionally, the single-view comparison (Table 5) shows Swin-B alone achieves only 75.0% vs. 83.9% for the full multi-view pipeline, demonstrating that the backbone alone cannot explain the gains. This concern is therefore real but substantially mitigated by the existing evidence.

- **Error propagation from incorrect auxiliary predictions in GALP is not analyzed.** The GALP module uses the *predicted* grade from the auxiliary head (not ground truth) to compute the class-specific CAM weights (Eq. 3). If the auxiliary head predicts the wrong grade, the CAM is computed for the wrong class, potentially misguiding proposal selection. The paper neither discusses this possibility nor reports how often auxiliary predictions are incorrect. While the auxiliary loss pushes predictions toward correctness and the overall results suggest robustness, the fragility should be disclosed.

### Trivial

- Several entries for SMVDR-W and SMVDR-M in Table 2 have missing Specificity values (shown as "-"), and the paper never explains why these metrics are unavailable.

## Nice-to-Haves

- **Lesion proposal validation using the available MFIDDR segmentation masks.** Computing patch-wise overlap between selected Top-K regions and actual lesion annotations would substantially strengthen the paper's core claim and is feasible since the dataset provides these masks.

- **Extending the fusion scope beyond a single cyclic neighbor.** An ablation comparing the current design to all-to-all or full-bidirectional fusion would either justify the restricted design or reveal additional gains.

- **Visualization of GEM maps and selected proposal regions** overlaid on original fundus images would greatly improve the paper's interpretability and help readers assess whether the method attends to clinically plausible regions.

- **Analysis of auxiliary classifier accuracy** to quantify how often the GALP module operates with incorrect grade predictions, and whether this meaningfully affects downstream performance.

## Removed Points

*These points were flagged by the harsh reviewer but are unjustified or already addressed, and are removed from the main review. Treat them with caution.*

- **"The ablation 'w/o GALP' uses all tokens making the comparison unfair due to token explosion."** REMOVED. The paper tokenizes the current-view feature map into Psn tokens regardless (Eq. 8). "Using all tokens" means using all patch tokens instead of the filtered top-K proposals — the token count is the same (Psn), just unfiltered. This is a valid and fair ablation that isolates the effect of selective proposal filtering.

- **"The load-balancing loss (Eq. 11) is ambiguous and not properly explained."** REMOVED. Eq. 11 follows the standard MoE load-balancing formulation used in the cited literature (Cao et al., 2023; Xie et al., 2025). The product-of-sums form is standard for encouraging uniform expert utilization. This is a formatting artifact issue, not a genuine weakness.

- **"Expert architecture dimensions, number of layers are omitted."** REMOVED. While more detail would help reproducibility, this is a minor implementation detail that does not affect the validity of the contribution. The paper provides sufficient architectural description for the method to be understood.

- **"The upper bound is set by externally informed methods and the unannotated variant does not beat WGLIN."** REMOVED. The paper explicitly acknowledges this: "the small residual differences with the strongest externally informed models are acceptable, given that our approach is fully external-annotation-free at inference" (Section 4.2). The paper's claim is about matching/surpassing *most* externally informed methods, not necessarily all, and on DRTiD the method does beat all externally informed methods. The asymmetry favors baselines, making this an unfair criticism under the stated rules.

## Novel Insights

The paper demonstrates that grade-conditioned CAM-based region selection, when coupled with a cross-view MoE fusion mechanism, can recover performance competitive with externally annotated methods — without requiring those annotations. This is a practically meaningful finding: even if the proposals are not validated as "lesions" in the clinical sense, the fact that a purely self-supervised saliency mechanism can narrow the gap with annotation-dependent methods is a useful empirical observation for the DR screening community. The LGRF's design of using current-view context to gate which experts process adjacent-view proposals is a clever inversion of standard MoE routing that could generalize to other multi-view medical imaging tasks.

## Suggestions

- **Validate the "lesion" label.** The most impactful improvement would be to compute overlap between selected proposals and the available MFIDDR lesion segmentation masks. If the overlap is high, the paper's central claim is substantially strengthened. If it is low, the authors should recalibrate their terminology (e.g., "grade-salient proposals") and adjust the narrative accordingly.

- **Report the auxiliary classifier's accuracy** and analyze how often incorrect auxiliary predictions occur. A simple table or paragraph showing that the auxiliary head achieves high accuracy (or that the method is robust to its errors) would close this analytical gap.

- **Add a fusion-scope ablation** (single-neighbor vs. all-to-all) to either justify or improve the current cyclic design.

- **Add qualitative examples** (GEM heatmaps overlaid on fundus images, with selected proposal bounding boxes) to improve the paper's interpretability and make the method more convincing to clinical readers.

## Score and Decision

### Calibration anchors used:

- `/home/wg25r/review_agent/human_reviews_2026/cESVZ0SfjA.md` — avg score 1.50 (Reject). "Label Transfer Hypothesis." Fundamentally flawed: no theory despite claiming one, trivial experiments, no SOTA baselines. Our paper is clearly far stronger.
- `/home/wg25r/review_agent/human_reviews_2026/mkoeblmWvN.md` — avg score 2.67 (Reject). "Semantic Robustness in Ophthalmology." Limited scope, narrow contribution. Our paper is stronger.
- `/home/wg25r/review_agent/human_reviews_2026/K5tcKEQaUr.md` — avg score 4.00 (Accept Poster). "RetMAE." Frequency-balanced MAE for retinal images. Solid but limited novelty and narrow experiments. Our paper has broader empirical scope and more architectural novelty but shares a domain-relevant weakness (some claims not fully validated). Roughly comparable — our paper is marginally stronger.
- `/home/wg25r/review_agent/human_reviews_2026/WuEE1f4NId.md` — avg score 4.00 (Withdrawn/Reject). "KCCL." Concept-based DR grading. Our paper's contribution is cleaner and better executed.
- `/home/wg25r/review_agent/human_reviews_2026/9gc58FeBba.md` — avg score 5.00 (Reject). "ProConMV." Multi-view DR with synthetic inputs, excessive complexity, marginal gains. Our paper has cleaner methodology and stronger results, so it sits above this.
- `/home/wg25r/review_agent/human_reviews_2026/S5Io33pc78.md` — avg score 6.50 (Accept Poster). "MAMMOTH." Extremely comprehensive MoE for MIL across 8 methods × 19 tasks. Our paper's experiments are narrower and the central claim about lesion proposals lacks direct validation, placing it clearly below this tier.
- `/home/wg25r/review_agent/human_reviews_2026/04HwYGgp2w.md` — avg score 6.50 (Accept Poster). Different domain (T2I evaluation), not directly comparable but represents the high-acceptance tier.
- `/home/wg25r/review_agent/human_reviews_2026/qsSIBK6nJX.md` — avg score 6.00 (Accept Poster). Different domain (pan-cancer screening), but similarly well-executed with clear validation.

**Score justification**: The paper makes a genuine contribution (GALP + LGRF modules, strong results, well-executed ablations) but the central claim about "lesion proposals" is a significant overreach without direct validation. It is stronger than the 4.00-tier papers (RetMAE, KCCL) in empirical breadth and novelty, and stronger than ProConMV (5.00) in methodological cleanliness, but weaker than the 6.00-6.50 tier which has airtight validation of core claims. Score: **5.0**.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>